Purchase Order 75D30123P17829
Award Date
9/12/23
Potential Completion Date
10/30/23
Potential Value
$212K
Federal Agency
CDC Pittsburgh
Awardee
XCR Diagnostics, Inc.
Ultimate Awardee
Fluoresentric, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $203,805.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing supplies, for laboratory reagents and supplies. This purchase order, which has no set-aside designation, will be performed in Salt Lake City, Utah and supports the CDC's diagnostic testing capabilities. XCR Diagnostics, Inc. is a wholly owned subsidiary of Fluoresentric, Inc.,...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fluoresentric, Inc., a manufacturer of goods registered to receive federal government awards. The contract, valued at $207,900.00, is for the provision of CBOT singleplex assays, which are laboratory reagents and diagnostic testing materials that support the CDC's mission of disease control and prevention. The contract has a firm fixed price pricing type and a performance period ending on August 7,...
This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $249,649.15 by the Centers for Disease Control and Prevention (CDC) to provide single-cell RNA-seq library preparation services. The purpose of this contract is to support CDC's efforts to study the host immune response induced by influenza vaccines through transcriptomic analysis at the single-cell level. Performance will take place in Atlanta, Georgia over a two week period...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract to Fluoresentric, Inc., a for-profit manufacturer of goods, for $207,900.00. The contract is for unspecified "other functions" and does not have a set-aside designation. The place of performance is Atlanta, GA. The contract period of performance ends on September 30, 2017.</p>